SynthesisFrontiers in pharmacology2022

Effectiveness and Safety of Anti-CD19 Chimeric Antigen Receptor-T Cell Immunotherapy in Patients With Relapsed/Refractory Large B-Cell Lymphoma: A Systematic Review and Meta-Analysis.

Zhitao Ying et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.